Venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of AML
Making cancer treatments more affordable
How can the study of familial leukemias help us to understand sporadic leukemias?
Jane E. Churpek
Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
ADCT-402 - a drug to watch